A class action suit is in the process of being filed against Guidant Corp. on behalf of approximately 18,000 patients who received Guidant's device used to treat aortic abdominal aneurysms, called the Ancure Endograft System. The company recently pled guilty to 10 felony charges from the US Food and Drug Administration for a penalty of $92.4 million dollars, admitting that they had mislead regulators about 12 deaths which have been linked to the device, as well as an unspecified number of injuries. The plaintiffs claim that the failure rate of the device is about one-third, and that they may ask for damages of up to $30 billion dollars.
If you feel you qualify for damages or remedies that might be awarded in this class action please fill in our form on the right to submit your complaint.
If your injustice does not match the complaint described above, please use this form to register your complaint. Thank you.
